New catheter device offers hope for men with enlarged prostate

NCT ID NCT06560476

Ongoing Symptom relief Sponsor: Urotronic Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tracks 500 men with symptomatic benign prostatic hyperplasia (BPH) who receive the Optilume BPH Catheter System in real-world clinics. The goal is to see how well the device eases urinary symptoms and how safe it is over 12 months. Participants must follow contraception rules and have no other implants or prostate cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN PROSTATIC HYPERPLASIA

Contacts and locations

Locations

Florida Urology Partners

Tampa, Florida, 33615, United States
Good Samaritan Hospital

Corvallis, Oregon, 97330, United States
Kearney Urology Center

Kearney, Nebraska, 68847, United States
Midtown Urology

Austin, Texas, 78705, United States
Northwell Health - Smith Institute of Urology

Syosset, New York, 11791, United States
Potomac Urology

Woodridge, Virginia, 22191, United States
Sheldon Freedman, Ltd

Las Vegas, Nevada, 89144, United States
The Urology Center, P.C.

Omaha, Nebraska, 68144, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.